Myocardial revascularization using on-pump beating heart among patients with left ventricular dysfunction

Ahmad K Darwazah1, Vivian Bader, Ismail Isleem

  • 1Department of Cardiac Surgery, Makassed Hospital, Jerusalem, Israel. darwaz30@hotmail.com

Insights

The on-pump beating heart technique offers better myocardial revascularization in patients with low ejection fraction but is associated with increased morbidity. This on-pump beating heart (ONCAB/BH) approach shows promise despite higher complication rates compared to off-pump coronary artery bypass (OPCAB).

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Anesthesia
  • Cardiology

Background:

  • The on-pump beating heart (ONCAB/BH) technique is established for myocardial revascularization but its use in patients with low ejection fraction (EF) is less explored.
  • Patients with reduced left ventricular function pose unique challenges for cardiac surgical procedures.

Purpose of the Study:

  • To evaluate the efficacy and safety of the on-pump beating heart technique in patients with ejection fraction below 0.35.
  • To compare the outcomes of ONCAB/BH with the off-pump beating heart (OPCAB) technique in this specific patient cohort.

Main Methods:

  • Retrospective analysis of 137 patients with EF < 0.35 undergoing isolated coronary artery bypass surgery.
  • Comparison between 39 patients in the ONCAB/BH group and 98 patients in the OPCAB group.
  • Evaluation of preoperative, operative, and postoperative variables, including graft success and complications.

Main Results:

  • ONCAB/BH group had more redo CABG cases (13% vs 3%).
  • Greater completeness of revascularization (72% vs 46%) and more grafts per patient (2.2 vs 1.7) in the ONCAB/BH group.
  • Higher incidence of blood loss, arrhythmias, inotropic support, and longer ICU/hospital stays in the ONCAB/BH group, though mortality and major morbidity were not significantly different.

Conclusions:

  • On-pump beating heart technique is feasible for myocardial revascularization in patients with left ventricular dysfunction.
  • The ONCAB/BH technique provides superior myocardial revascularization compared to OPCAB.
  • Increased morbidity necessitates careful consideration when selecting the ONCAB/BH approach for these high-risk patients.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...